Hait’s planned retirement comes after a 17-year run with the healthcare giant, starting back in 2007 when he joined J&J’s Janssen arm as senior vice president and therapeutic area head of hematology and oncology.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,